The Inaugural Stem Cell Meeting will be held on March 12-14 at the Palace Hotel in San Francisco, CA. The event is the premier international event bringing together world renowned scientists at the frontier of embryonic and adult stem cell research with decision makers and thought leaders in policy, ethics, patient advocacy, finance, business, and media to explore the challenge and promise of stem cell research and the compelling potential of emerging therapies.
The event Molecular BioProducts: VWR and Nalge Nunce BioProducts Lunch & Learn will be held on Thursday, March 9th from 11:30 to 1:00 p.m. at the Molecular BioProducts Main Offices, 9880 Mesa Rim Road, San Diego, CA 92121. The event will examine new products for cell culture and cell-based research.
Category:
Biotech Industry Events |
Comments Off on Molecular BioProducts: VWR and Nalge Nunce BioProducts Lunch & Learn
The event Molecular BioProducts: VWR and Nalge Nunce BioProducts Lunch & Learn will be held on Thursday, March 9th from 11:30 to 1:00 p.m. at the Molecular BioProducts Main Offices, 9880 Mesa Rim Road, San Diego, CA 92121. The event will examine new products for cell culture and cell-based research.
Category:
Biotech Industry Events |
Comments Off on Molecular BioProducts: VWR and Nalge Nunce BioProducts Lunch & Learn
The International Society for Pharmaceutical Engineering, San Francisco/Bay Area Chapter will be holding the 15th Annual Vendor Night on March 9, 2006 between 5:00-8:00 p.m. at the South San Francisco Conference Center.
The U.S. Commercial Service, San Francisco will hold an Asia Biotech Webinar on March 8th, 2006 at 3:30 p.m. PST, which will take a look at prevailing strategies for the Asian market, best practices, strategic alliances and partners, market prospects and prudent steps needed in order to succeed overseas.
The event BIO Intellectual Property Counsel’s Committee Spring Meeting will be held on March 8-10, 2006 at The Palace Hotel in San Francisco, CA. The event will provide a discussion on topics such as the PTO’s proposed rule changes, patent reform suggestions, and technology transfer concerns. Registration is limited to BIO members.
California Life Sciences Day at the State Capitol will be held on March 7, 2006 in Sacramento, CA. The day will kick off with a breakfast at the California Chamber of Commerce, California Room, 1215 K Street, 14th Floor, Sacramento, CA 95814.
The event California’s Stem Cell Initiative: Confronting the Legal & Policy Challenges will be held at UC Berkeley’s Boalt Hall School of Law on March 2-4, 2005. The three-day conference will focus on such issues as “Getting Intellectual Property Rights Right: What Model Should Be Adopted,” “How Can the State Recoup its Investment (or should it?)” and “The Political Process and Stem Cell Research: How Did We Get Here and What Can We Learn?” The event will provide up to 14.5 hours of MCLE credit.
Category:
Biotech Industry Events |
Comments Off on California’s Stem Cell Initiative: Confronting the Legal and Policy Challenges
The 2nd International Conference on Stem Cell Research and Therapeutics will be held on March 2-3, 2006 at the San Francisco Airport Mariott in Burlingame, CA. The keynote speaker is Jeffery D. Kocsis, PhD, Professor, Department of Neurology and Neurobiology, Yale University Associate Director, PVA-EPVA Center for Neuroscience and Regeneration Research, Senior Research Career Scientist, Department of Veterans Affairs.
Category:
Biotech Industry Events |
Comments Off on 2nd International Conference on Stem Cell Research and Therapeutics
Cooley Godward will be sponsoring the CEO Summit 2006 on Thursday, March 2, 2006 from 11 a.m.-6:30 p.m. at the Omni San Diego Hotel, 675 L. St., San Diego, CA 92101. The event is invitation only and will will provide life science chief officers (CEOs and CFOs) and the BIOCOM Board of Directors the opportunity to discuss issues relevant to their companies and to interact with each other. The keynote speaker will be Billy Tauzin, President and Chief Executive Officer of the Pharmaceutical Research and Manufacturers of America (“PhRMA”).